The global injectable drug delivery market is set for remarkable growth, projected to reach USD 1,139.4 billion by 2029 from an estimated USD 754.5 billion in 2024, expanding at a robust CAGR of 8.6% during the forecast period.
Key Growth Drivers:
# Technological Advancements: Innovative drug delivery technologies are enhancing the effectiveness and precision of injectable treatments.
# Chronic Diseases on the Rise: The aging global population and increasing incidence of chronic diseases like diabetes, cancer, and cardiovascular conditions are driving demand for injectable medications.
# Government Funding: Significant government investments in healthcare infrastructure are fueling market growth.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150
Emerging Market Opportunities:
Rapid urbanization and improved healthcare infrastructure in emerging economies are expanding access to injectable drugs, prompting pharmaceutical companies to extend their presence in these markets.
Infectious Diseases Lead Therapeutic Applications
Injectable vaccinations play a crucial role in preventing infectious diseases by stimulating the immune system. Vaccines for diseases like influenza, measles, polio, hepatitis, and COVID-19 are administered intramuscularly or subcutaneously. Injectable treatments are also essential in managing chronic infectious diseases such as tuberculosis (TB) and HIV/AIDS.
Curative Care Dominates Usage Patterns
Injectable drugs are widely used in curative care settings like hospitals and emergency rooms for treating acute medical conditions. They provide targeted therapies based on patient-specific characteristics, genetic profiles, and disease biomarkers. This precision is particularly beneficial in administering monoclonal antibodies, immunotherapies, and gene therapies.
Hospitals: Fastest-Growing End Users
Hospitals, encompassing various medical disciplines, require injectable drugs for diagnosis, treatment, and prevention. These drugs are integral in surgeries, diagnostic imaging, interventional radiology, and therapeutic interventions, contributing to the growing demand in hospital settings.
North America Leads the Market
North America holds the largest market share due to high healthcare expenditures, advanced medical technologies, and comprehensive healthcare insurance systems. The region’s world-class clinical research institutes and pharmaceutical research hubs foster innovation and the translation of scientific discoveries into clinical practice.
Prominent Market Players:
Key players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Sandoz (Germany), Terumo (Japan), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), Bespak (U.K.), and B. Braun Melsungen (Germany).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
